Related Experiment Video
Updated: Dec 24, 2025

Author Spotlight: Unraveling the Pathogenesis of Age-Related Macular Degeneration and Discovering Potential Therapies
Published on: July 28, 2023
Design, development and deployment of a web-based patient registry for rare genetic lipid disorders
Kathryn R Napier1, Amanda J Hooper2, David M Ng3
1Centre for Comparative Genomics, Murdoch University, Murdoch, WA, Australia.
Insights
A new web-based patient registry was developed for rare genetic lipid disorders to improve monitoring and research. This registry aims to enhance diagnosis, management, and treatment strategies for these complex conditions.
Area of Science:
- Medical Genetics
- Metabolic Disorders
- Bioinformatics
Background:
- Rare genetic lipid disorders are monogenic disorders of lipoprotein metabolism, excluding heterozygous familial hypercholesterolaemia (FH).
- Patient registries are crucial for disease monitoring, clinical practice improvement, research facilitation, and therapeutic development.
- Existing disease-specific registries for rare genetic lipid disorders are scarce.
Purpose of the Study:
- To design, develop, and deploy a web-based patient registry for rare genetic lipid disorders.
- To establish a platform for longitudinal data collection on 13 rare genetic lipid disorders, with future expandability.
- To leverage the FH Australasia Network (FHAN) Registry model and the open-source Rare Disease Registry Framework (RDRF).
Main Methods:
- Development of a web-based patient registry using the Rare Disease Registry Framework (RDRF).
- Adaptation of the established FH Australasia Network (FHAN) Registry infrastructure.
- Implementation of a system for capturing longitudinal data on multiple rare genetic lipid disorders.
Main Results:
- Successful design, development, and deployment of the Rare Genetic Lipid Disorders Registry.
- The registry is based on the RDRF, ensuring efficient customization and sustainable deployment.
- The registry is capable of capturing longitudinal data for 13 specific rare genetic lipid disorders.
Conclusions:
- The developed registry provides a critical tool for monitoring and research in rare genetic lipid disorders.
- The web-based, adaptable framework allows for future expansion across Australia and internationally.
- Data collected may significantly improve the diagnosis, management, and treatment of these rare conditions.
Abstract:
Rare genetic lipid disorders comprise all the monogenic disorders of lipoprotein metabolism with the exception of heterozygous familial hypercholesterolaemia (FH). The creation and maintenance of patient registries is critical for disease monitoring, improving clinical best practice, facilitating research and enabling the development of novel therapeutics, but very few disease-specific rare genetic lipid disorder registries currently exist. Our aim was to design, develop and deploy a web-based patient registry for rare genetic lipid disorders. The Rare Genetic Lipid Disorders Registry is based on the FH Australasia Network (FHAN) Registry, which has been operating since 2015. The Rare Genetic Lipid Disorders Registry was deployed utilising the open-source Rare Disease Registry Framework (RDRF), which enables the efficient customisation and sustainable deployment of web-based registries. The Registry has been designed to capture longitudinal data on 13 rare genetic lipid disorders, with the ability to add more if required in the future. Recruitment of volunteers into the Registry is currently through the Royal Perth Hospital Lipid Disorders Clinic in Western Australia. Although in essence a clinic-based patient registry, the web-based design allows for expansion and distribution across Australia and beyond. Data collated by the Registry may ultimately improve the diagnosis, management and treatment of these conditions.
Related Concept Videos
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Pedigree Analysis

